论文部分内容阅读
Glaxo 公司3月8日在英国上市其新的吸入式肾上腺皮质激素类药,氟替卡松丙酸盐(fluticasone propionate),商品名为Flixotide,治疗哮喘。这是该产品获准用于哮喘的第一个国家。该公司称,由于氟替可松具有更高的局
Glaxo marketed its new inhaled corticosteroid, fluticasone propionate, marketed as Flixotide in the United Kingdom on March 8 to treat asthma. This is the first country the product is approved for asthma. The company said higher levels of flutter may be available